Migrant Disparities in Atherosclerotic Cardiovascular Complications among Persons with Type 2 Diabetes

被引：0
|
作者：
Andersen, Gregers S.
Byberg, Stine
Bjorkman, Anne-Sofie D.
Isaksen, Anders A.
Amadid, Hanan
Carstensen, Bendix
Jorgensen, Marit E.
机构：
来源：
DIABETES | 2020年 / 69卷
关键词：
D O I：
10.2337/db20-1491-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1491-P
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Cardiovascular health among persons with HIV without existing atherosclerotic cardiovascular disease
    McLaughlin, Megan M.
    Durstenfeld, Matthew S.
    Gandhi, Monica
    Greene, Meredith
    Ma, Yifei
    Beatty, Alexis L.
    Hsue, Priscilla Y.
    [J]. AIDS, 2023, 37 (14) : 2179 - 2183
  • [32] Risk factors for macrovascular complications and mortality in persons with type 2 diabetes
    Pedula, KL
    Brown, JB
    Hillier, TA
    [J]. DIABETES, 2000, 49 : A146 - A146
  • [33] Assessment of the benefits from a "polypill" to reduce cardiovascular disease among persons with type 2 diabetes mellitus
    Sorensen, S
    Engelgau, M
    Hoerger, T
    Hicks, K
    Narayan, KMV
    Williamson, DF
    Vinicor, F
    Thompson, T
    Zhang, P
    Bowman, B
    [J]. DIABETES, 2004, 53 : A294 - A294
  • [34] Quantifying the Impact of Influenza on Cardiovascular Health Outcomes and Activity Among Persons With Type 2 Diabetes Mellitus
    Samson, Sandrine
    Lee, Wei-Nchih
    Quisel, Tom
    Foschini, Luca
    Liska, Jan
    Mills, Henry
    Hollingsworth, Rosalind
    Greenberg, Michael
    Beal, Anne
    [J]. CIRCULATION, 2018, 138
  • [35] How to ADVANCE prevention of cardiovascular complications in type 2 diabetes
    Grobbee, DE
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2003, 52 (08): : 24 - 28
  • [36] Efficacy and Safety of Alirocumab in Persons with Type 1 or Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease in 10 ODYSSEY Phase 3 Trials
    Ganda, Om P.
    Plutzky, Jorge
    Sanganalmath, Santosh K.
    Bujas-Bobanovic, Maja
    Koren, Andrew
    Mandel, Jonas
    Leiter, Lawrence A.
    [J]. DIABETES, 2017, 66 : A59 - A59
  • [37] Inflammatory Cytokines and the Risk of Cardiovascular Complications in Type 2 Diabetes
    Mahmoud, Fadia
    Al-Ozairi, Ebaa
    [J]. DISEASE MARKERS, 2013, 2013 : 235 - 241
  • [38] Health literacy and cardiovascular complications in people with type 2 diabetes
    Vieira, Maria
    Rosendo, Ines
    Gomes, Pedro
    Santiago, Luiz Miguel
    Domingues, Ana Catarina
    Simoes, Jose Augusto
    [J]. FAMILY MEDICINE AND PRIMARY CARE REVIEW, 2021, 23 (04): : 488 - 493
  • [39] Sphingolipid metabolism in type 2 diabetes and associated cardiovascular complications
    Sui, Jing
    He, Mingqian
    Wang, Yue
    Zhao, Xinrui
    He, Yizhi
    Shi, Bingyin
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (05) : 3603 - 3614
  • [40] Sex and ethnic differences in the cardiovascular complications of type 2 diabetes
    Yeo, Jian L.
    Brady, Emer M.
    McCann, Gerry P.
    Gulsin, Gaurav S.
    [J]. THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2021, 12
12345